Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/39676
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Molina-Guijarro, José M. | - |
dc.contributor.author | Macías, Álvaro | - |
dc.contributor.author | García Rodríguez, Carolina | - |
dc.contributor.author | Muñoz, Eva | - |
dc.contributor.author | García-Fernández, Luis F. | - |
dc.contributor.author | David, Miren | - |
dc.contributor.author | Núñez, Lucía | - |
dc.contributor.author | Lillo, M. Pilar | - |
dc.contributor.author | Villalobos, Carlos | - |
dc.contributor.author | Valenzuela, Carmen | - |
dc.date.accessioned | 2011-09-19T11:31:24Z | - |
dc.date.available | 2011-09-19T11:31:24Z | - |
dc.date.issued | 2011-04-27 | - |
dc.identifier.citation | PLoS ONE 6(4): e19402 (2011) | es_ES |
dc.identifier.uri | http://hdl.handle.net/10261/39676 | - |
dc.description | This is an open-access article distributed under the terms of the Creative Commons Attribution License.-- et al. | - |
dc.description.abstract | Irvalec is a marine-derived antitumor agent currently undergoing phase II clinical trials. In vitro, Irvalec induces a rapid loss of membrane integrity in tumor cells, accompanied of a significant Ca(2+) influx, perturbations of membrane conductivity, severe swelling and the formation of giant membranous vesicles. All these effects are not observed in Irvalec-resistant cells, or are significantly delayed by pretreating the cells with Zn(2+). Using fluorescent derivatives of Irvalec it was demonstrated that the compound rapidly interacts with the plasma membrane of tumor cells promoting lipid bilayer restructuration. Also, FRET experiments demonstrated that Irvalec molecules localize in the cell membrane close enough to each other as to suggest that the compound could self-organize, forming supramolecular structures that likely trigger cell death by necrosis through the disruption of membrane integrity. | es_ES |
dc.description.sponsorship | This work was supported by Ministerio de Ciencia e Innovación (MICINN), Spain (SAF2007-65868, SAF2010-14916, Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS RD06/0014/0006 to CV, PIF200680F0023, S-BIO-0260/2006, CTQ 2009-12412 to MPL). MD and AM hold RECAVA contract and JAEPredoc Grant, respectively. | - |
dc.language.iso | eng | es_ES |
dc.publisher | Public Library of Science | es_ES |
dc.relation.isversionof | Publisher's version | - |
dc.rights | openAccess | es_ES |
dc.subject | Kahalalide-f | es_ES |
dc.subject | Hkv1.5 channels | es_ES |
dc.subject | Block | es_ES |
dc.subject | Cancer | es_ES |
dc.title | Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cells | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1371/journal.pone.0019042 | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1371/journal.pone.0019042 | es_ES |
dc.identifier.e-issn | 1932-6203 | - |
dc.identifier.pmid | 21556352 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IIBM) Artículos (IQF) Artículos (IBGM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Irvalec Inserts.pdf | 4,1 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
8
checked on 16-abr-2024
SCOPUSTM
Citations
28
checked on 13-abr-2024
WEB OF SCIENCETM
Citations
28
checked on 26-feb-2024
Page view(s)
380
checked on 19-abr-2024
Download(s)
301
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.